Home     Version française    Corporate    Contact Webmaster

Free search :


ALL OFFERS

CONTACT

New biodegradable microspheres formulated in pressurized CO2
Application to the encapsulation and controlled release of active compounds
- Protein loaded PLGA microspheres
- Protein loaded CaCO3 microspheres
- Impregnated CaCO3 microspheres


Propionyl-coA precursors for the treatment of poly-glutamine diseases
Anaplerotic Krebs cycle stimulators as therapeutic targets
- Metabolic action
- Blood-Brain Barrier permeant


Novel Human HER-2/neu antibody fragment
A promising cancer vaccine candidate
- Adjuvant therapy in association with standard strategie
- Cancer relapse prevention
- No immunotolerance problem


Bioactive coatings made of polyelectrolyte multilayers
- Different sort of molecules may be included in the film
- Small molecules of PM<5000Da and even PM<1000 Da keep their activity
- Activity is stable up to 50 layers depth


A new generation of polyelectrolyte multilayer film's system
- Multifonctionalized bioactive materials
- Tuned activity of the molecules
- New properties due to the mixture of polycations and polyanions


A new kit for pronostic and therapeutic of colorectal cancers
Better patient classification for high-risk of relapse than TMN histological
- A novel approach for the analysis of the intra-tumoral immune infiltrate
- Better predictive value than the gold-standard histologic classification
- Stratification of patients at high risk of relapse


ThyX, a novel thymydilate synthase and related inhibitors
- THYX: dTMP route synthesis of mostly pathogenic bacteria
- Mutual exclusion of Thyx and thya in the genome of bacteria and viruses
- The human genome does not bear theThyx gene


Use of novel flagellin- derived peptides as mucosal adjuvant

- TLR5 agonist
- No significant systemic pro-inflammatory effects


Polymorphisms in the EPCR gene and thrombotic risk
- EPCR receptor responsible for thrombosis
- Differenciation of 3 haplotypes for the EPCR gene
- Diagnostic kit for thrombotic risks


A novel marker of sensitivity or resistance to anti-tumoral treatment
Theranostic kit for chemotherapy
- Vascular Endothelial Cadherin, a body fluids protein
- Detection in plasma or serum
- Brain solid tumors (glioblastoma) but currently investigating other cancers


Broad applications of a crosslinked polyelectrolyte multilayer film
- An infinite variety of architectures
- A long term use of this film due to the important stability
- Neither allergic reaction nor excessive inflammatory response


Anti-Restenosis by MRP4 gene inhibition
- siRNA proof of concept in vivo
- drugable membrane protein


Spatiotemporal cartography Software by multiple-target tracing method probe
High Throughput screening software for multiple targets
- Tracing over 1000 simulataneous targets
- In heterogeneous media with high noise
- Dynamic tracing as well (instantanous)


Method for quantifyingVEGF121/VEGF 165 isoforms in a biological sample
Prognosis of survival in solid cancer and AML
- Linked to angiogenesis
- Poor and bad prognosis of event-free and overall survival
- Extremely sensitive detection of isoform


A method for predicting the responsiveness to anti-TNFa antibody treatment
IL15 and sIL15Ra implicated in the response to treatment in Crohn's disease
- Inflammatory disease and Biomarker in Crohn's disease
- Response to Infliximab in Crohn's disease
- A specific modulation of IL15 and sIL15Ra


An in-vitro method for expanding monocytes
- Application #1: cell models for research and screening
- Application #2: cell-based biotherapies
- In-vitro method based on inactivation of MafB and c-Maf genes in monocytes


Artemis,a gene implied in DNA reparation and VDJ recombination
- Gene therapy for the SCID: severe combined immunodeficiency.
- Radiosensible SCID observed in this study.
- Identification of the implication of a gene in SCID.


the NPHS2 gene implicated in steroid-resistant nephrotic syndrome
- NPHS2: identified and mapped to chromosom 1
- A hot spot of mutation
- Prediction of reccurence after transplant


human Skin substitutes from Human Pluripotent Stem Cell
1st truly established skin substitutes worldwide
- Application in screening and toxicology
- Provide all possible phenotypes
- Skin lines with reproductible results


A new treatment for glomerulonephritis
- EFGR antagonist or inhibitor of EFGR for treatment
- CD9 implied in the EGFR activation
- Enlargement of treatment to other alloimune diseases


Prediction of the responsiveness to a treatment for Multiple sclerosis
- The first useful biomarker for multiple sclerosis diagnostic
- Identification of a group receptive to IFN-β treatment
- Reduction of the public health costs


Fluorescent Nano diamonds and its method of production
Use as a labeling marker/tool for research, in-vitro diagnostic
- Consistent and permanent fluorescence
- Replicable and industrial process, classical surface chemistry
- Can bind to any biologicals (DNA, RNA, protein, etc)


Methods for the treatment,the prognostic and the detection of breast cancer
Early diagnosis-differentiate at stage 0 between calcification and tumor
- Diagnostic imaging of breast cancer. Relapse prognosis.
- Alternative to MRI-based mammography (false positive and higher cost)
- Radiotherapy and therapeutic application


A strategy to generate new compound conformations with enhanced efficacy
The concept : sublimation under vaccum followed by solid deposition
- Sublimation followed by deposition alters compound conformation
- Compound conformation of the deposit gains in therapeutic efficacy
- Gain in efficacy reflects gain in bioavailability or biological activity


CD31-derived fragment for the treatment of atherosclerosis
A new therapeutic window through immunoregulation
- Diagnosis + Therapeutic proof of concept on the target
- Minimal peptidic sequence identified
- Significant clinical evidence


CNF1 and related Rho GTPases activators as adjuvant for mucosal vaccination
- Product: CNF1 bacterial toxin as adjuvant
- Application: mucosal vaccination, proof of concept in nasal and oral models
- Novel action mechanism: transient and reversible activation of Rho-GTPases


Identification of genetic markers associated to cancer of pancreas
CNV-based biomarker in sporadic pancreatic cancer
- Diagnostic of a predisposition to the pancreatic cancer
- Inhibitor of the genes proteins activities for the treatment
- Identification of a CNV signature.


New polypeptides in cancer therapy
- HSP70: a new therapeutic target
- Smaller inhibitors for an easier use
- Peptidic aptameres as therapeutic agents


Novel antibacterials for treating latent tuberculosis
Novel original target from dormant tuberculosis bacillus (TB)
- Product: carbapenems
- Target: L,D-transpeptidase, expressed in dormant tuberculosis bacillus (TB)
- Indication: latent tuberculosis


The role of a phosphotase PTPL1 as survival prognostic in breast cancer
- Biomarker of breast and ovaries cancers: PTPL1
- Development of an immunocytochemistry dosage
- Diagnostic and prognostic tests


Novel imaging agents for fibrosis (lung, heart, liver)
- Fibrosis diagnosis
- Lysil Oxidase Enzyme binders as imaging agents
- Acute treatment should be provided


Prognostic of breast cancer development into local metastasis (bone, lung)
- Molecular signatures of osseous and lung metastasis
- Experiments on human samples
- Targeted therapy


Inhibitor of STIM1 for the treatment of cardiovascular disorders
- STIM1: a protein that activates NFAT
- NFAT induces cells proliferation and cardiac hypertrophy
- RNA interference to inhibit STIM1


Antagonists and agonists mutants of humans IL-15
Control of the IL-15 affinity for its receptor IL-15α
- Interleukin-15 induces NK and T cell proliferation and activation
- Development of new IL-15 mutants
- Prevention and treatment of human pathology by IL-15 activity modulation


Interleukin-15 receptor: a biomarker of survival for head and neck cancers
- Prediction of survival in HNSCC patients
- Increase level of soluble IL-15Rα in HNSCC patients
- soluble α chain: biomarker of these cancers


Microsensor of arterial pressure
- Non-invasive pulse wave velocity measurement
- High fidelity pressure microsensor
- Vascular alteration prognostic


Method for predicting therapeutics responsiveness to TNF-a blocking agents
Inflammation and Biomarker in Rheumatoid Arthritis (RA)
- Polymorphisms of the TNF gene : identification of a single TNF haplotype
- A single TNF haplotype influences the response of Adalimumab in RA
- Large pharmacogenetic study


Methods of classification and prognosis of hepatocellular carcinoma
- HCC is an heterogeneous group of tumours
- A reliable classification for adapted treatments
- 6 distinct subgroups from genotype-phenotype correlation


Biomarker for liver lesions diagnosis of obese patients
- Diagnosis devoid from risk
- Free hemoglobin as biomarker
- Studies on both morbid and non-morbid obesity


Early diagnosis of prostate cancer using a protein receptor
Imaging, In vitro diagnostic, radiotherapy and immunotherapy
- Protein Receptor expressed in vascular cells for prognosis
- Expressed in prostate tumors and other solid cancers
- Imaging application, Development of tumor blood test


Methods for the prognosis or for the diagnosis of a thyroid disease
- Molecular classification
- Marker genes for thyroid disease diagnosis
- Precise identification of all thyroid diseases


A gene-based classifier for prognosis in multiple myeloma
Prognosis of disease outcome for treatment selection
- More acurate patient stratification than current ISS standard
- Especially for high risk patients
- Blood sample


Highly Sensitive Prion Detection Technology
- Chemical-based amplification of the pathological prion protein
- Applicable to human and animal samples


Use of HB-19 pseudo-peptide to inhibit infection by Francisella tularensis
- Product #1: HB-19 and related compounds, specific ligands of nucleolin
- Product #2: EF-Tu of F. Tularensis as a vaccine
- Novel targets: EF-Tu / cell surface nucleolin interaction


Novel diagnostic agent of the liver function reserve (LFR)
Radiopharmaceuticals with simplified preparation
- Binds specifically to hepatocytes
- Safe and cost efficient (based on human albumin)
- Scintigraphic agent (technetium)


Fusion proteins for optimal antigen presentation in vaccine strategy
- Optimized fusion protein for efficient antigen processing
- Specific monoclonal antibody targeting dendritic cells


A novel therapeutic vaccine approach for resistant pathogens
- Product: vaccine (preventive and therapeutic)
- Novel therapeutic vaccination method
- Novel action mechanism: CCL3 dépendant


Uridine derivatives as antivirals against a flaviviridae, especially HCV
- Product: inhibitors of HCV replication


Prognosis and diagnosis of agressiveness of non small cell lung cancer
Based on a protein and its corresponding receptor
- Diagnostic imaging of non small cell lung (potentially colon, breast) cance
- Monitoring of cancer Severity and its progression
- In-vitro diagnostic and radiotherapy


New Gossypol derivatives promotes apoptosis in cancer cells
- Chemical familly already in clinical development
- Specific inhibition of the bcl2 family
- Chemical Therapy orally available


        1 - 2     Suivant   >>

Special features

3 D Porous hydrogels providing a scaffold with lamellar pores

CNF1 and related Rho GTPases activators as adjuvant for mucosal vaccination

Inhibitor of STIM1 for the treatment of cardiovascular disorders

Use of agonists of integrin alpha 5 for bone repair and regeneration

The role of a phosphotase PTPL1 as survival prognostic in breast cancer

Innovative therapeutic tools for rheumatic diseases

Peptidic antagonist of Neuropilin-1

Method for predicting therapeutics responsiveness to TNF-a blocking agents

Serological methods and Kits for the diagnosis of Rheumatoid Arthritis (RA)

A method for predicting the responsiveness to anti-TNFa antibody treatment

Polymorphism and genetic susceptibility to thyroid dysgenesis

3D Porous hydrogels

Early diagnosis of prostate cancer using a protein receptor

New biodegradable microspheres formulated in pressurized CO2

A new kit for pronostic and therapeutic of colorectal cancers

LEGAL INFORMATION INSERM TRANSFERT © copyright 2008 S'abonner au flux RSS